Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02154776 |
| Title | Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. (LeeBLet) |
| Acronym | LeeBLet |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California at Los Angeles UCLA SC | Los Angeles | California | 90095 | United States | Details | |
| Horizon Oncology Center SC | Lafayette | Indiana | 47905 | United States | Details | |
| Medical University of South Carolina SC | Charleston | South Carolina | 29425 | United States | Details | |
| South Texas Accelerated Research Therapeutics SC | San Antonio | Texas | 78922 | United States | Details | |
| University of Utah / Huntsman Cancer Institute SC-3 | Salt Lake City | Utah | 84103 | United States | Details | |
| Novartis Investigative Site | Madrid | 28007 | Spain | Details |